Venu G Pillarisetty (Venu Pillarisetty)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaofei Zhang, Ruoxin Lan, Yongjun Liu, Venu G Pillarisetty, Danting Li, Chaohui L Zhao, Suparna A Sarkar, Weiguo Liu, Iman Hanna, Mala Gupta, Cristina Hajdu, Jonathan Melamed, Michael Shusterman, Jessica Widmer, John Allendorf, Yao-Zhong Liu
Enhanced Complement Expression in the Tumor Microenvironment Following Neoadjuvant Therapy: Implications for Immunomodulation and Survival in Pancreatic Ductal Adenocarcinoma. Research square (2024)
Xiaofei Zhang, Ruoxin Lan, Yongjun Liu, Venu G Pillarisetty, Danting Li, Chaohui Zhao, Suparna Sarkar, Weiguo Liu, Iman Hanna, Mala Gupta, Cristina Hajdu, Jonathan Melamed, Michael Shusterma, Jessica Widmer, John Allendorf, Yao-Zhong Liu
Enhanced Complement Expression in the Tumor Microenvironment Following Neoadjuvant Therapy: Implications for Immunomodulation and Survival in Pancreatic Ductal Adenocarcinoma. Research square (2024)
Kevin P Labadie, Shannon A Kreuser, Katherine J Brempelis, Sara K Daniel, Xiuyun Jiang, Kevin M Sullivan, Alan F Utria, Heidi L Kenerson, Teresa S Kim, Courtney A Crane, Venu G Pillarisetty
Production of an interleukin-10 blocking antibody by genetically engineered macrophages increases cancer cell death in human gastrointestinal tumor slice cultures. Cancer gene therapy (2023)
Lindsay Kathleen Dickerson, Jason A Carter, Karan Kohli, Venu G Pillarisetty
Emerging interleukin targets in the tumour microenvironment: implications for the treatment of gastrointestinal tumours. Gut (2023)
Harrison K Chinn, Jennifer L Gardell, Lisa R Matsumoto, Kevin P Labadie, Tara N Mihailovic, Nicole A P Lieberman, Amira Davis, Venu G Pillarisetty, Courtney A Crane
Hypoxia-inducible lentiviral gene expression in engineered human macrophages. Journal for immunotherapy of cancer 10 (6) (2022)
Kevin M Sullivan, Xiuyun Jiang, Prajna Guha, Christopher Lausted, Jason A Carter, Cynthia Hsu, Kevin P Labadie, Karan Kohli, Heidi L Kenerson, Sara K Daniel, Xiaowei Yan, Changting Meng, Arezou Abbasi, Marina Chan, Y David Seo, James O Park, Ian Nicholas Crispe, Raymond S Yeung, Teresa S Kim, Taranjit S Gujral, Qiang Tian, Steven C Katz, Venu G Pillarisetty
Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases. Gut (2022)
Karan Kohli, Venu G Pillarisetty, Teresa S Kim
Key chemokines direct migration of immune cells in solid tumors. Cancer gene therapy (2021)
Steven C Katz, Venu G Pillarisetty
Silver linings at the bench and bedside. Cancer gene therapy 27 (10-11) (2020)
Shihong Zhang, Karan Kohli, R Graeme Black, Lu Yao, Sydney M Spadinger, Qianchuan He, Venu G Pillarisetty, Lee D Cranmer, Brian Andrew Van Tine, Cassian Yee, Robert H Pierce, Stanley R Riddell, Robin L Jones, Seth M Pollack
Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial. Cancer immunology research 7 (8) (2019)
Louis F Chai, Ethan Prince, Venu G Pillarisetty, Steven C Katz
Challenges in assessing solid tumor responses to immunotherapy. Cancer gene therapy 27 (7-8) (2019)
Cristina P Rodriguez, Qian Vicky Wu, Jenna Voutsinas, Jonathan R Fromm, Xiuyun Jiang, Venu G Pillarisetty, Sylvia M Lee, Rafael Santana-Davila, Bernardo Goulart, Christina S Baik, Laura Q M Chow, Keith Eaton, Renato Martins
A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (4) (2019)
Ru Chen, Lisa A Lai, Yumi Sullivan, Melissa Wong, Lei Wang, Jonah Riddell, Linda Jung, Venu G Pillarisetty, Teresa A Brentnall, Sheng Pan
Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer. Scientific reports 7 (1) (2017)

Venu G Pillarisetty.css-eqlu8i{font-size:small;padding-left:4px;} (Venu Pillarisetty)

Publication Activity (10 Years)

Top Topics

Top Venues

Venu G Pillarisetty (Venu Pillarisetty)